Cargando…
Erratum: Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study
Autores principales: | Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770780/ |
Ejemplares similares
-
Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study
por: Baba, Hideo, et al.
Publicado: (2015) -
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
por: Miarons, Marta, et al.
Publicado: (2023) -
TFEB
‐translocated and ‐amplified renal cell carcinoma with
VEGFA
co‐amplification: A case of long‐term control by multimodal therapy including a vascular endothelial growth factor‐receptor inhibitor
por: Takamori, Hajime, et al.
Publicado: (2023) -
A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
por: Tong, Chi C., et al.
Publicado: (2018) -
Polymorphisms of GSTP1, ERCC2 and TS-3′UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients
por: KUMAMOTO, KENSUKE, et al.
Publicado: (2013)